| |
|
Jens
Kindtler - M.Sc., EPA, MBA, Chairman of the Board of Directors,
Partner BankInvest Biomedical Venture
Jens Kindtler joined BankInvest Biomedical Venture in early 2001.
He focuses on corporate transactions such as M&A, licensing,
financing, exits and Intellectual Property Rights. [more]
|
|
|
Christopher Wright - M.A., Non
Executive Director
Christopher
is a director of Merifin Capital Group, a private European investment
firm and an advisory director of Campbell Lutyens & Co Ltd,
a London based investment bank. [more]
|
|
|
Shane
Kelly - Chief Executive Officer.
Shane
has extensive experience in financing, operating and managing early
and mid size growth companies. [more]
|
|
|
Jeff
Edwards - PhD, Non
Executive Director
Jeff spent most of his career in the pharmaceutical industry with
many years experience of antimicrobial drug discovery, development
and registration. [more]
|
|
Robert
Nolan - PhD, Non Executive Director
Dr Nolan was director of global licensing in AstraZeneca plc, until
he retired at the end of 2004. [more] |
|
|
Richard
White - PhD, Non-executive director
Richard has a wealth of experience in infectious disease drug discovery.
[more]
|
F2G
Ltd, PO Box 1, Lankro Way, Eccles, Manchester, M30 0BH
Tel +44 (0)161 785 1270 Fax +44 (0)161 785 1273 Email contact@f2g.com
|